Baillie Gifford & Co’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
|
|||||
|
2024
Q3 | $3.78M | Sell |
|
|||||
|
2024
Q2 | $10.1M | Sell |
|
|||||
|
2024
Q1 | $11.8M | Sell |
|
|||||
|
2023
Q4 | $10.3M | Sell |
|
|||||
|
2023
Q3 | $9.4M | Sell |
|
|||||
|
2023
Q2 | $14.6M | Sell |
|
|||||
|
2023
Q1 | $14.8M | Buy |
|
|||||
|
2022
Q4 | $14M | Sell |
|
|||||
|
2022
Q3 | $16.5M | Buy |
|
|||||
|
2022
Q2 | $15.2M | Sell |
|
|||||
|
2022
Q1 | $19.6M | Sell |
|
|||||
|
2021
Q4 | $24.7M | Sell |
|
|||||
|
2021
Q3 | $751M | Sell |
|
|||||
|
2021
Q2 | $799M | Buy |
|
|||||
|
2021
Q1 | $602M | Buy |
|
|||||
|
2020
Q4 | $655M | Sell |
|
|||||
|
2020
Q3 | $537M | Sell |
|
|||||
|
2020
Q2 | $873M | Buy |
|
|||||
|
2020
Q1 | $667M | Sell |
|
|||||
|
2019
Q4 | $706M | Sell |
|
|||||
|
2019
Q3 | $641M | Sell |
|
|||||
|
2019
Q2 | $589M | Buy |
|
|||||
|
2019
Q1 | $499M | Sell |
|
|||||
|
2018
Q4 | $552M | Buy |
|
|||||
|
2018
Q3 | $558M | Buy |
|
|||||
|
2018
Q2 | $500M | Sell |
|
|||||
|
2018
Q1 | $479M | Sell |
|
|||||
|
2017
Q4 | $416M | Buy |
|
|||||
|
2017
Q3 | $378M | Buy |
|
|||||
|
2017
Q2 | $379M | Sell |
|
|||||
|
2017
Q1 | $355M | Sell |
|
|||||
|
2016
Q4 | $313M | Sell |
|
|||||
|
2016
Q3 | $334M | Buy |
|